Bioniq is a health tech startup based in the United Kingdom, founded in 2019. The company's mission is to revolutionize personalized health with their innovative approach. Bioniq has developed a proprietary biochemical database and patented technology to create personalized supplements for health optimization. These products are backed by science and have garnered recommendations from world-leading medical institutions.
The company's slogan, "Your ultimate personalized supplements. Clinically proven and backed by science," encapsulates their commitment to providing tailored and scientifically validated health solutions. Bioniq's recent Series B investment of $15.00M, led by HV Capital and Unbound on 16 July 2024, reflects the confidence of investors in the company's potential for growth and innovation within the Health Care, Health and Wellness, and Sports industries.
For individuals seeking a personalized approach to health and wellness, Bioniq offers an enticing opportunity to explore their products and embark on a journey towards better health. With their strong foundation and recent backing, Bioniq is well-positioned to further disrupt the health tech landscape and make a lasting impact on personalized health solutions.
No recent news or press coverage available for Bioniq.